C12N 9/0091
Oxidizing metal ions
Official title: {oxidizing metal ions (1.16)}
C12N9/0091 (Oxidizing metal ions) appears on 81 US grants and 127 published applications in this corpus.
Search patents in C12N- Granted patents
- 81
- Published applications
- 127
- Assignees
- 42
- Inventors
- 141
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 3 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 1 | 0 |
| 2010 | 0 | 3 |
| 2011 | 3 | 1 |
| 2012 | 1 | 4 |
| 2013 | 4 | 8 |
| 2014 | 4 | 30 |
| 2015 | 13 | 2 |
| 2016 | 3 | 5 |
| 2017 | 4 | 15 |
| 2018 | 9 | 3 |
| 2019 | 8 | 5 |
| 2020 | 4 | 4 |
| 2021 | 1 | 11 |
| 2022 | 5 | 13 |
| 2023 | 4 | 5 |
| 2024 | 2 | 4 |
| 2025 | 8 | 5 |
| 2026 | 2 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Genetically encoded fluorescent-iron ferritin nanoparticle probes for detecting an intracellular target by fluorescent and electron microscopy2 Jun 2026US 12,643,929 B2The Salk Institute for Biological Studies
- Using synthetic lixiviant biology for the recovery of precious and toxic metals from anthropogenic sources24 Mar 2026US 12,584,191 B2National University of Singapore
- Anti-microbial and UV-protective extracts and methods of making and using thereof4 Nov 2025US 12,460,212 B2Biocapital Holdings, LLC
- Methods for screening host cells expressing target proteins15 Apr 2025US 12,275,953 B2Industrial Technology Research Institute
- Peptides and combination of peptides for use in immunotherapy against various cancers18 Feb 2025US 12,226,467 B2Immatics Biotechnologies GmbH
- Compositions and methods for base editing a phenylalanine hydroxylase polynucleotide9 Jul 2026US 2026/0193645 A1Beam Therapeutics Inc.
- In vivo production of proteins25 Jun 2026US 2026/0174909 A1ModernaTX, Inc.
- Protein having laccase activity26 Feb 2026US 2026/0055380 A1Nagase & Co., Ltd.
- Anti-microbial and uv-protective extracts and methods of making and using thereof8 Jan 2026US 2026/0009039 A1Biocapital Holdings, LLC
- Sequence for protein decay25 Sep 2025US 2025/0297290 A1
Most cited
By later US patents
- Modified polynucleotides for the production of biologics and proteins associated with human disease196US 8,999,380 B2Moderna Therapeutics, Inc. · 2015
- Modified polynucleotides for treating protein deficiency194US 9,061,059 B2Moderna Therapeutics, Inc. · 2015
- Modified polynucleotides encoding copper metabolism (MURR1) domain containing 1124US 9,095,552 B2Moderna Therapeutics, Inc. · 2015
- Modified polynucleotides encoding citeD4124US 9,114,113 B2Moderna Therapeutics, Inc. · 2015
- Modified polynucleotides for treating galactosylceramidase protein deficiency121US 9,089,604 B2Moderna Therapeutics, Inc. · 2015